| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB201503387AGB201503387D0 (en) | 2015-02-27 | 2015-02-27 | Anti-carbapenem antibodies and uses thereof | 
| PCT/EP2015/079487WO2016092096A1 (en) | 2014-12-11 | 2015-12-11 | Anti-carbapenemase antibodies and uses thereof | 
| EP15808247.9AEP3230741A1 (en) | 2014-12-11 | 2015-12-11 | Anti-carbapenemase antibodies and uses thereof | 
| Application Number | Priority Date | Filing Date | Title | 
|---|---|---|---|
| GB201503387AGB201503387D0 (en) | 2015-02-27 | 2015-02-27 | Anti-carbapenem antibodies and uses thereof | 
| Publication Number | Publication Date | 
|---|---|
| GB201503387D0true GB201503387D0 (en) | 2015-04-15 | 
| Application Number | Title | Priority Date | Filing Date | 
|---|---|---|---|
| GB201503387ACeasedGB201503387D0 (en) | 2014-12-11 | 2015-02-27 | Anti-carbapenem antibodies and uses thereof | 
| Country | Link | 
|---|---|
| EP (1) | EP3230741A1 (en) | 
| GB (1) | GB201503387D0 (en) | 
| WO (1) | WO2016092096A1 (en) | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| JP7437000B2 (en) | 2016-07-01 | 2024-02-22 | パラクライン セラピューティクス アーベー | Methods and compositions for inhibition of PDGF-CC | 
| EP3856787A4 (en) | 2018-09-27 | 2022-06-29 | Celgene Corporation | SIRPalpha BINDING PROTEINS AND METHODS OF USE THEREOF | 
| US11591390B2 (en) | 2018-09-27 | 2023-02-28 | Celgene Corporation | SIRP-α binding proteins and methods of use thereof | 
| CN113150138B (en)* | 2021-02-01 | 2022-07-29 | 深圳市龙华区疾病预防控制中心 | KPC-2 monoclonal antibody, and preparation method and application thereof | 
| CN112501131B (en)* | 2021-02-07 | 2021-05-04 | 天津一瑞生物科技股份有限公司 | anti-IMP (anti-IMP) carbapenemase hybridoma cell strain, monoclonal antibody and application | 
| CN112980803B (en)* | 2021-05-12 | 2021-07-30 | 天津一瑞生物科技股份有限公司 | Anti-VIM carbapenemase hybridoma cell line, monoclonal antibody and application | 
| CN112980804B (en)* | 2021-05-12 | 2021-09-10 | 天津一瑞生物科技股份有限公司 | KPC (Klebsiella pneumoniae Carbapenemase) resistant hybridoma cell strain, monoclonal antibody and application | 
| CN114149988B (en)* | 2022-02-10 | 2022-05-06 | 丹娜(天津)生物科技股份有限公司 | Carbapenemase conserved antigen, antibody and application thereof | 
| CN114317454B (en)* | 2022-03-01 | 2023-10-03 | 天津一瑞生物科技股份有限公司 | Mouse anti-OXA-48 type carbapenemase hybridoma cell strain, monoclonal antibody and application | 
| CN114316056A (en)* | 2022-03-02 | 2022-04-12 | 天津一瑞生物科技股份有限公司 | A mouse anti-NDM carbapenemase hybridoma cell line, monoclonal antibody and application | 
| CN114755420B (en)* | 2022-05-30 | 2023-02-03 | 广东聚诚生物技术有限公司 | Carbapenemase combined detection kit | 
| Publication number | Priority date | Publication date | Assignee | Title | 
|---|---|---|---|---|
| FI20095544A0 (en)* | 2009-05-15 | 2009-05-15 | Juha Kirveskari | Method and kit for identifying antibiotic resistant bacteria | 
| US20120219952A1 (en)* | 2009-10-06 | 2012-08-30 | Patrice Nordmann | Carbapenemase and antibacterial treatment | 
| US9551020B2 (en)* | 2011-04-21 | 2017-01-24 | Biomerieux, Inc. | Method of detecting at least one mechanism of resistance to carbapenems by mass spectrometry | 
| WO2013011072A1 (en)* | 2011-07-20 | 2013-01-24 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Carbapenemase and antibacterial treatment | 
| WO2013112696A1 (en)* | 2012-01-27 | 2013-08-01 | Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center | Compositions and methods for immunization against bacteria expressing a carbapenemase | 
| CN110308272B (en)* | 2013-03-13 | 2023-09-12 | 中尺度技术有限责任公司 | Improved measurement method | 
| Publication number | Publication date | 
|---|---|
| WO2016092096A1 (en) | 2016-06-16 | 
| EP3230741A1 (en) | 2017-10-18 | 
| Publication | Publication Date | Title | 
|---|---|---|
| IL283321A (en) | Anti-muc16 antibodies and uses thereof | |
| IL258284A (en) | Anti-lag3 antibodies and uses thereof | |
| IL257263A (en) | Anti-angptl8 antibodies and uses thereof | |
| ZA201800536B (en) | Il-8-binding antibodies and uses thereof | |
| IL254954A0 (en) | Anti-pacap antibodies and uses thereof | |
| IL252804B (en) | Anti-c10orf54 antibodies and uses thereof | |
| IL251248A0 (en) | Anti-interleukin-33 antibodies and uses thereof | |
| ZA201605894B (en) | Anti-egfrviii antibodies and uses thereof | |
| IL265689A (en) | Anti-il-33 antibodies and uses thereof | |
| ZA201701663B (en) | Anti-il-25 antibodies and uses thereof | |
| RS62912B1 (en) | Anti-human-her3 antibodies and uses thereof | |
| GB201503387D0 (en) | Anti-carbapenem antibodies and uses thereof | |
| IL266082A (en) | Anti-chikv antibodies and uses thereof | |
| IL264417A (en) | Anti-o2 antibodies and uses thereof | 
| Date | Code | Title | Description | 
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |